Literature DB >> 6814317

Factor VIII activity and thyroid function.

J S Rogers, S R Shane, F S Jencks.   

Abstract

Plasma factor VIII coagulant activity is decreased in hypothyroid patients and increased in hyperthyroid patients. We studied 21 untreated hypothyroid patients. Factor VIII coagulant activity was mildly decreased in association with significant depression of factor-VIII-related antigen and ristocetin cofactor activity in five patients. Factor-VIII-related properties significantly increased with oral thyroid replacement therapy in seven of 10 patients. Twenty-two untreated hyperthyroid patients were similarly evaluated. In 21 of these patients significant increases were noted in factor VIII coagulant activity, factor-VIII-related antigens, and ristocetin cofactor activity. Elevated factor-VIII-related properties returned to normal in all of 10 patients treated with radioactive iodine or propylthiouracil. We discuss the relation between thyroid function and factor-VIII-related properties in both hypothyroid and hyperthyroid patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814317     DOI: 10.7326/0003-4819-97-5-713

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

1.  Hypothyroidism and increased bleeding tendency.

Authors:  I B Johnstone
Journal:  Can Vet J       Date:  1988-08       Impact factor: 1.008

Review 2.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

3.  Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment.

Authors:  F Marongiu; M Conti; G Mameli; M L Murtas; S Balzano; G Sorano; A M Mamusa; E Martino
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

4.  Plasma fibronectin and thyroid function.

Authors:  W Graninger; K Pirich; K Derfler; W Waldhäusl
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

5.  Blood coagulation and fibrinolysis in patients with hyperthyroidism.

Authors:  C Erem; H O Ersoz; S S Karti; K Ukinç; A Hacihasanoglu; O Değer; M Telatar
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

6.  Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism.

Authors:  A Ata Alturfan; Ebru Emekli Alturfan; Nuran Dariyerli; Emel Zengin; Erman Aytac; Gunnur Yigit; Emine Kokoglu
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

7.  Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

Authors:  C De Ciuceis; A Pilu; C Cappelli; E Porteri; F Zani; A Santoro; E Gandossi; G E M Boari; N Rizzardi; M Castellano; D Rizzoni; E Agabiti Rosei
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

Review 8.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

9.  Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2008-09-12       Impact factor: 2.300

10.  The role of hyperthyroidism as the predisposing factor for superior sagittal sinus thrombosis.

Authors:  Jong-Uk Hwang; Ki-Young Kwon; Jin-Woo Hur; Jong-Won Lee; Hyun-Koo Lee
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.